© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
October 27, 2020
New data presented at ACG 2020 shows NER1006 bowel preparation to be safe and efficacious in patients with diabetes preparing for their colonoscopy.
Researchers test 3 different doses of mirikizumab in both biologic experienced and naïve Crohn’s disease patients.
Ustekinumab resulted in a reduction of both stool frequency and rectal bleeding for ulcerative colitis patients.
New research shows patients with chronic liver disease admitted for influenza had an increased risk of disease severity but not a higher odds of mortality.
More than half of the patient population achieved a defined response at both day 14 and week 6.
New phase 1 data show the first-in-class oral therapy is not affected by the burden on metabolism via hepatic or renal disease.